Veradigm (Veradigm) Risk Assessment

View and export this data going back to 1999. Start your Free Trial

What is Veradigm Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Veradigm is: No Data: Cannot be evaluated.

Competitive Comparison of Veradigm's Risk Assessment

For the Health Information Services subindustry, Veradigm's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Veradigm's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Veradigm's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Veradigm's Risk Assessment falls into.

Veradigm (OTCPK:MDRX) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Veradigm Risk Assessment Related Terms

Thank you for viewing the detailed overview of Veradigm's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Veradigm (Veradigm) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Veradigm Inc (OTCPK:MDRX) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

222 Merchandise Mart Plaza, Suite 2024, Chicago, IL, USA, 60654

Website

https://www.veradigm.com

Veradigm Inc is a healthcare technology company that drives value through its various combination of platforms, data, expertise, connectivity, and scale. It delivers a combination of point-of-care clinical and financial solutions. The Veradigm Network features a dynamic community of solutions and partners providing insights, technology, and data-driven solutions, all working together to transform healthcare insightfully.

Executives

Shih Yin Ho	director	222 MERCHANDISE MART, SUITE 2024, CHICAGO IL 60654
Susan Rodriguez	director	C/O ARDELYX, INC., 34175 ARDENWOOD BLVD, SUITE 200, FREMONT CA 94555
Richard J. Poulton	officer: CFO	3646 WESTFIELD LANE, GLENVIEW IL 60026
Tejal Vakharia	officer: SVP Gerneral Counsel	222 MERCHANDISE MART PLZ, SUITE 2024, CHICAGO IL 60654
David B Stevens	director	1 IMATION WAY, OAKDALE MN 55128
Leah Jones	officer: Chief Financial Officer	222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Paul Black	director	400 WOOD ROAD, BRAINTREE MA 02184
Elizabeth Ann Altman	director	10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Thomas Langan	officer: President and CCO	222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Lisa Hammond	officer: SVP & Chief HR Officer	305 CHURCH AT NORTH HILLS STREET, RALEIGH NC 27609
Greg Garrison	director	222 MERCHANDISE MART PLAZA, CHICAGO IL 60654
Lisa Khorey	officer: Chief Client Delivery Officer	222 MERCHANDISE MART PLAZA, CHICAGO IL 60654
Michael Klayko	director
Carol J Zierhoffer	director	100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022
Brian Farley	officer: SVP Gerneral Counsel & Corpora	222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654